- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 224436
Total 1221 results
-
Boehringer IngelheimNot yet recruitingIdiopathic Pulmonary Fibrosis | Progressive Pulmonary Fibrosis
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimRecruitingLiposarcoma, DedifferentiatedUnited States, Australia, Canada, United Kingdom, Japan
-
Boehringer IngelheimRecruitingKidney Disease, ChronicUnited States, Belgium, Australia, Spain, Germany, France, Italy, New Zealand, United Kingdom, China, Ireland
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimActive, not recruitingBronchiectasisSpain, United States, Denmark, Belgium, Korea, Republic of, Canada, Italy, Japan, Bulgaria, Australia, Latvia, Netherlands, United Kingdom, Germany, Israel, France, Hungary, Mexico, Greece, Poland, Turkey, Czechia, Portugal
-
Boehringer IngelheimActive, not recruiting
-
Boehringer IngelheimCompletedNon-alcoholic Steatohepatitis (NASH)United States, Spain, Korea, Republic of, United Kingdom, Australia, Canada, Singapore, Germany, Italy, Malaysia, China, France, Japan, Netherlands, Taiwan, Austria, Israel, New Zealand, Poland, Hong Kong, Belgium, Czechia, Greece, Hu... and more
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedNon-cystic Fibrosis BronchiectasisUnited Kingdom, Germany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedSafety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular EdemaMacular EdemaSpain, United Kingdom, Germany, Portugal, France, Belgium, Hungary, Greece
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Dr Phillip J BuckhurstBMI Southend HospitalCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthy | AsthmaUnited Kingdom
-
Boehringer IngelheimCompletedDiabetic RetinopathyUnited States, United Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHepatitis C, ChronicUnited States, Australia, Austria, France, Germany, New Zealand, Portugal, Romania, Spain, Switzerland
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimNot yet recruiting
-
Boehringer IngelheimRecruitingPsoriasisBulgaria, Romania, Moldova, Republic of, Georgia
-
Northwell HealthRecruitingProstate Cancer | Magnetic Resonance Imaging | Population at RiskUnited States
-
Boehringer IngelheimRecruitingSolid TumorsUnited States, Japan, Canada
-
Boehringer IngelheimRecruitingNeoplasm Metastasis | Non-Small Cell Lung CancerHong Kong, Spain, Korea, Republic of, United States, China, Israel, Germany, Japan, Singapore, Australia, United Kingdom, Austria, Netherlands, France, Portugal, Belgium, Sweden, Italy
-
Boehringer IngelheimCompletedPost-Traumatic Stress DisorderUnited States, Germany, Sweden, Finland, Israel, Poland, Mexico, Croatia
-
Boehringer IngelheimCompletedChronic Kidney DiseaseSpain, Canada, Australia, United States, Japan, Malaysia, United Kingdom, China, Mexico, Denmark, Russian Federation, Germany, Portugal, Hong Kong, Poland, Argentina, New Zealand, Sweden
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedBorderline Personality DisorderSpain, Germany, Sweden, United States, Mexico, Argentina, France, Poland, Australia, Belgium, Bulgaria, Czechia, Denmark, Italy, Japan
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthyKorea, Republic of
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimTerminatedCOVID-19Spain, United States, Mexico, Brazil, Chile, Puerto Rico
-
Boehringer IngelheimCompleted